Marrone Bio Innov (MBII) Misses Q1 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
Marrone Bio Innovations Reports First Quarter 2014 Financial Results
May 13, 2014 4:02 PM EDTGained EPA approval and commercially launched Venerate bioinsecticide Completed installation of two 20,000 liter fermentation tanks at our Michigan facility and initiated commercial production of fermentation products Re-iterates guidance to at least double revenues year-over-year
DAVIS, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (Nasdaq: MBII), a provider of bio-based pest management and plant health products, today announced financial results for the first quarter March 31, 2014.
Financial Highlights for the First Quarter of 2014
Revenues for the first quarter 2014 totaled $2.8 million, compared to... More


